State Street Corp raised its stake in Entrada Therapeutics, Inc. (NASDAQ:TRDA – Free Report) by 5.5% during the 3rd quarter, according to the company in its most recent disclosure with the Securities ...
Some results have been hidden because they may be inaccessible to you